Levallorphan
| Levallorphan | |
|---|---|
| Salts [] | |
|---|---|
| Levallorphan tartrate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 283.40 g/mol [1] |
| Appearance | CRYSTALS FROM DILUTE ETHANOL [1] |
| Melting point | 181 °C [1] |
| Solubility | 633 mg/L [1] |
| Predicted LogP | 3.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C19H25NO |
| IUPAC name | (1R,9R,10R)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol |
| SMILES | C=CCN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O |
| InChI | InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18+,19+/m0/s1 |
| InChIKey | OZYUPQUCAUTOBP-QXAKKESOSA-N |
| CAS number | 152-02-3 |
| UNII | 353613BU4U |
| PubChem CID | 5359371 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Oral |
Levallorphan (also known as Naloxiphan, Levallorphane, 17-Allylmorphinan-3-ol, Levalorfano, Levallorphanum, Levallofano, N-Allyl-3-hydroxymorphinan, L-N-Allyl-3-hydroxymorphinan, (-)-3-Hydroxy-N-allylmorphinan or Levo-3-hydroxy-N-allyl morphinan) is a opioid and opioid antagonist substance of the 2-benzylpiperidine and morphinan class.
Chemistry
Salts []
Levallorphan is typically found in the form of its tartrate salt.
Stereochemistry []
Levallorphan is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Levallorphan matches Lipinski's rule of five.Reagents
There are currently 3 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | yellow-brown | |
| Froehde | no color change |
Pharmacology
MeSH Classification
- narcotic antagonists (M0014474)
Mechanism of action []
Levallorphan antagonizes opioid effects by competing for the same receptor sites. It binds to the opioid mu receptor and the nicotinic acetylcholine receptor alpha2/alpha3. [1]
Subjective effects []
Legal status []
- Other: Levallorphan is a Rx-only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5359371, Levallorphan. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5359371
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Levallorphan. UNII: 353613BU4U. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/353613BU4U
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 11:17:12 |
| drugspro | ok | 2026-11-20 11:17:08 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 11:17:08 |
| gsrs | ok | 2026-11-20 11:17:09 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014647) | 2026-11-20 11:17:08 |
| kegg | ok | 2026-11-20 11:17:10 |
| pubchem | ok | 2026-11-20 11:17:07 |
| missing (no r/tripreports posts mention it) | 2026-11-20 11:17:08 | |
| sider | missing (not in SIDER) | 2026-11-20 11:17:08 |
| structure | ok | 2026-11-20 11:17:08 |
| wikipedia | ok | 2026-11-20 11:17:08 |